Titre : Azépines

Azépines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Azépines : Questions médicales les plus fréquentes", "headline": "Azépines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Azépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-14", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Azépines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétéromonocycliques", "url": "https://questionsmedicales.fr/mesh/D006573", "about": { "@type": "MedicalCondition", "name": "Composés hétéromonocycliques", "code": { "@type": "MedicalCode", "code": "D006573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dilazep", "alternateName": "Dilazep", "url": "https://questionsmedicales.fr/mesh/D004109", "about": { "@type": "MedicalCondition", "name": "Dilazep", "code": { "@type": "MedicalCode", "code": "D004109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.200" } } }, { "@type": "MedicalWebPage", "name": "Meptazinol", "alternateName": "Meptazinol", "url": "https://questionsmedicales.fr/mesh/D008621", "about": { "@type": "MedicalCondition", "name": "Meptazinol", "code": { "@type": "MedicalCode", "code": "D008621", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.400" } } }, { "@type": "MedicalWebPage", "name": "Oxazépines", "alternateName": "Oxazepines", "url": "https://questionsmedicales.fr/mesh/D010077", "about": { "@type": "MedicalCondition", "name": "Oxazépines", "code": { "@type": "MedicalCode", "code": "D010077", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.498" } } }, { "@type": "MedicalWebPage", "name": "Pentétrazol", "alternateName": "Pentylenetetrazole", "url": "https://questionsmedicales.fr/mesh/D010433", "about": { "@type": "MedicalCondition", "name": "Pentétrazol", "code": { "@type": "MedicalCode", "code": "D010433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.066.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Azépines", "alternateName": "Azepines", "code": { "@type": "MedicalCode", "code": "D001381", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peng An", "url": "https://questionsmedicales.fr/author/Peng%20An", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Ranran Li", "url": "https://questionsmedicales.fr/author/Ranran%20Li", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Bin Zhang", "url": "https://questionsmedicales.fr/author/Bin%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Yi-Kang Zhang", "url": "https://questionsmedicales.fr/author/Yi-Kang%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China." } }, { "@type": "Person", "name": "Sylvian Cretton", "url": "https://questionsmedicales.fr/author/Sylvian%20Cretton", "affiliation": { "@type": "Organization", "name": "Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Erratum: Non-cardia early gastric cancer in Central Vietnam: noticeable uncommon background mucosa and results of endoscopic submucosal dissection.", "datePublished": "2022-08-22", "url": "https://questionsmedicales.fr/article/36003304", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1925-4922" } }, { "@type": "ScholarlyArticle", "name": "Imaging-Based Deep Graph Neural Networks for Survival Analysis in Early Stage Lung Cancer Using CT: A Multicenter Study.", "datePublished": "2022-07-13", "url": "https://questionsmedicales.fr/article/35936706", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2022.868186" } }, { "@type": "ScholarlyArticle", "name": "Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35790091", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cnr2.1672" } }, { "@type": "ScholarlyArticle", "name": "Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients.", "datePublished": "2022-06-28", "url": "https://questionsmedicales.fr/article/35836600", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fsurg.2022.905575" } }, { "@type": "ScholarlyArticle", "name": "Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.", "datePublished": "2022-05-26", "url": "https://questionsmedicales.fr/article/35616747", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-022-11754-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Azépines", "item": "https://questionsmedicales.fr/mesh/D001381" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Azépines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Azépines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Azépines", "description": "Comment diagnostiquer un trouble d'anxiété ?\nQuels tests sont utilisés pour évaluer l'anxiété ?\nLes azépines sont-elles prescrites pour d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nComment différencier l'anxiété normale de l'anxiété pathologique ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Azépines", "description": "Quels sont les symptômes courants de l'anxiété ?\nLes azépines peuvent-elles provoquer des effets secondaires ?\nComment l'anxiété se manifeste-t-elle physiquement ?\nQuels signes indiquent une crise d'angoisse ?\nLes symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Azépines", "description": "Comment prévenir les troubles anxieux ?\nLes techniques de relaxation sont-elles efficaces ?\nL'éducation sur l'anxiété peut-elle aider ?\nLe soutien social joue-t-il un rôle dans la prévention ?\nLes azépines peuvent-elles être utilisées en prévention ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Azépines", "description": "Comment les azépines agissent-elles sur l'anxiété ?\nQuels sont les principaux azépines prescrites ?\nLes azépines sont-elles addictives ?\nComment se déroule un traitement avec azépines ?\nLes azépines peuvent-elles être combinées avec d'autres traitements ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Azépines", "description": "Quelles complications peuvent survenir avec les azépines ?\nLes azépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les risques d'un sevrage brutal ?\nLes azépines peuvent-elles affecter la mémoire ?\nComment gérer les complications liées aux azépines ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Azépines", "description": "Quels sont les facteurs de risque pour l'anxiété ?\nL'âge influence-t-il le risque d'anxiété ?\nLe sexe joue-t-il un rôle dans l'anxiété ?\nLes antécédents médicaux augmentent-ils le risque ?\nLe mode de vie peut-il influencer l'anxiété ?", "url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble d'anxiété ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation des symptômes et l'exclusion d'autres troubles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'anxiété ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles d'évaluation psychologique et des entretiens cliniques sont utilisés." } }, { "@type": "Question", "name": "Les azépines sont-elles prescrites pour d'autres troubles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour les troubles du sommeil et les crises d'angoisse." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la durée des symptômes et leur impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Comment différencier l'anxiété normale de l'anxiété pathologique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété pathologique est persistante, excessive et interfère avec le fonctionnement quotidien." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'anxiété ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'inquiétude excessive, l'irritabilité et les troubles du sommeil." } }, { "@type": "Question", "name": "Les azépines peuvent-elles provoquer des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme la somnolence, la confusion et des troubles de la mémoire peuvent survenir." } }, { "@type": "Question", "name": "Comment l'anxiété se manifeste-t-elle physiquement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des palpitations, des tremblements et des douleurs musculaires." } }, { "@type": "Question", "name": "Quels signes indiquent une crise d'angoisse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une peur intense, des palpitations, des sueurs et des sensations d'étouffement." } }, { "@type": "Question", "name": "Les symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en intensité et en type selon les individus." } }, { "@type": "Question", "name": "Comment prévenir les troubles anxieux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La gestion du stress, l'exercice régulier et une bonne hygiène de vie peuvent aider." } }, { "@type": "Question", "name": "Les techniques de relaxation sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la méditation et le yoga peuvent réduire l'anxiété." } }, { "@type": "Question", "name": "L'éducation sur l'anxiété peut-elle aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre l'anxiété et ses mécanismes peut aider à mieux la gérer." } }, { "@type": "Question", "name": "Le soutien social joue-t-il un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon réseau de soutien social peut réduire le risque de troubles anxieux." } }, { "@type": "Question", "name": "Les azépines peuvent-elles être utilisées en prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont généralement pas recommandées pour la prévention en raison du risque de dépendance." } }, { "@type": "Question", "name": "Comment les azépines agissent-elles sur l'anxiété ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles augmentent l'effet du GABA, un neurotransmetteur inhibiteur, réduisant ainsi l'anxiété." } }, { "@type": "Question", "name": "Quels sont les principaux azépines prescrites ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les principales incluent le diazépam, le lorazépam et l'alprazolam." } }, { "@type": "Question", "name": "Les azépines sont-elles addictives ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation prolongée peut entraîner une dépendance et un sevrage difficile." } }, { "@type": "Question", "name": "Comment se déroule un traitement avec azépines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement commence généralement par une faible dose, ajustée selon la réponse du patient." } }, { "@type": "Question", "name": "Les azépines peuvent-elles être combinées avec d'autres traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être combinées avec des thérapies cognitivo-comportementales pour une efficacité accrue." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les azépines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dépendance, le sevrage et des troubles cognitifs." } }, { "@type": "Question", "name": "Les azépines peuvent-elles interagir avec d'autres médicaments ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec des antidépresseurs et des analgésiques, augmentant les risques." } }, { "@type": "Question", "name": "Quels sont les risques d'un sevrage brutal ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un sevrage brutal peut entraîner des symptômes graves comme des convulsions et des hallucinations." } }, { "@type": "Question", "name": "Les azépines peuvent-elles affecter la mémoire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des troubles de la mémoire, surtout à forte dose ou sur le long terme." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux azépines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut une réduction progressive de la dose et un suivi médical régulier." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour l'anxiété ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le stress, les antécédents familiaux et des événements traumatiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'anxiété ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes et les personnes âgées sont souvent plus à risque." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans l'anxiété ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont généralement plus susceptibles de souffrir de troubles anxieux que les hommes." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de dépression ou de troubles mentaux augmentent le risque d'anxiété." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer l'anxiété ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Imaging-Based Deep Graph Neural Networks for Survival Analysis in Early Stage Lung Cancer Using CT: A Multicenter Study.

Lung cancer is the leading cause of cancer-related mortality, and accurate prediction of patient survival can aid treatment planning and potentially improve outcomes. In this study, we proposed an aut... In this retrospective study, we segmented 10 parts of the lung CT images and built individual lung graphs as inputs to train a GCN model to predict 5-year overall survival. A Cox proportional-hazard m... A total of 1,705 patients (main cohort) and 125 patients (external validation cohort) with lung cancer (stages I and II) were included. The GCN model was significantly predictive of 5-year overall sur... The proposed GCN model outperformed all ML, Tumor-CNN, and TNM staging models. This study demonstrated the value of utilizing medical imaging graph structure data, resulting in a robust and effective ...

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience.

Holmium laser enucleation of the prostate (HoLEP) is commonly performed in patients with significant bladder outlet obstruction. However, there are few reports on the toxicity of external beam irradia... Eighteen patients who had HoLEP and subsequently received RT for prostate cancer were included. Data collected included patient and disease characteristics, urinary function, and radiation dose. Acute... Median follow-up was 18 months (range: 4-46 months). Median prostate volume was 107 ml before HoLEP and 24 ml after HoLEP. Median International Prostate Symptom Score (IPSS) was 17 (range: 5-32) befor... Patients who received RT as definitive treatment for prostate cancer after prior HoLEP had low risk of serious acute and late side effects. HoLEP can be safely performed and should be considered in pa...

Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients.

To investigate the association of Ki-67 change pattern after core needle biopsy (CNB) and prognosis in HR+/HER2- early breast cancer patients.... Eligible patients were categorized into three groups: Low group, Elevation group, and High group. Chi-square test and logistic regression analysis were used to compare the clinic-pathological characte... A total of 2,858 patients were included: 1,179 (41.3%), 482 (16.9%), and 1,197 (41.8%) patients were classified into the low, elevation, and high groups, respectively. Age, tumor size, histological gr... Ki-67 change after CNB was associated with prognosis in HR+/HER2- early breast cancer. Patients with Ki-67 high or elevation after CNB had an inferior disease outcome, indicating the necessity of re-e...

Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.

Malnutrition commonly affects patients with esophageal cancer and has the potential to negatively influence treatment outcomes. The aim of this study was to investigate the impact of early (preoperati... Patients were selected to undergo early JTF during neoadjuvant chemoradiotherapy (nCRT) in accordance with European Society for Clinical Nutrition and Metabolism (ESPEN) and Enhanced Recovery after Su... In total, 81 patients received early JTF and 91 patients received routine JTF. Patients who received early JTF had lower body mass index (BMI; 26.1 ± 4.6 vs. 28.4 ± 4.9; p = 0.002), greater weight los... In patients determined to be at 'high risk' of malnutrition, early JTF may prevent excess morbidity after esophagectomy with an associated relative preservation of parameters of body composition....

Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.

The limited understanding of long-term estradiol (E2) suppression poses challenges to the effectiveness of adjuvant therapy with aromatase inhibitors (AI), necessitating comprehensive serum E2 monitor... In this prospective cohort study, we recruited women who had received adjuvant AI treatment, including those who underwent ovarian function suppression (OFS). Serum E2 levels were measured using high-... A total of 706 patients were enrolled, including 482 women with OFS in combination with AI. Among them, 116 women (16.4 %) exhibited E2 levels exceeding 2.72 pg/mL. The majority of serum E2 elevations... Despite receiving adjuvant AI treatment for nearly two years, a certain proportion of patients failed to achieve the adequate threshold of E2 suppression. Our findings emphasize the significance of mo...

Comparison of clinical outcomes in women with surgically treated early primary cervical cancer: Lymphadenectomy versus sentinel lymph node biopsy.

The primary objective of this study was to elucidate the impact of sentinel lymph node (SLN) mapping and biopsy techniques on the clinical outcomes of women with early primary cervical cancer.... All consecutive women with clinically determined stage I-IIA cervical cancer who underwent lymph node assessment with either SLN mapping or conventional pelvic/para-aortic lymphadenectomy were reviewe... Women in the SLN group (n=33) had fewer total dissected pelvic nodes (8.3±5.9 versus 17.4±7.7, p<0.001), less intraoperative blood loss (513±332mL versus 1228±1170mL, p<0.001), a shorter length of hos... SLN biopsy does not seem to be associated with an inferior survival outcome compared with conventional lymphadenectomy in women with early primary cervical cancer. In addition, it is associated with l...

Comparison analysis of the burden and attributable risk factors of early-onset and late-onset colorectal cancer in China from 1990 to 2019.

The project intended to analyze the impact of burden and related risk factors of late-onset colorectal cancer (LOCRC) and early-onset colorectal cancer (EOCRC) in China, thus offering essential refere... Global Burden of Disease Study was employed to describe burden changes of EOCRC and LOCRC in China during 1990-2019, containing the numbers of incidence, deaths, prevalence, and disability-adjusted li... The numbers and corresponding crude rates of incidence, deaths, prevalence, and DALYs of EOCRC and LOCRC in China during 1990-2019 demonstrated an upward trend across all age categories, with males be... The burden of colorectal cancer in China is concerning. Patients grouped by diagnostic age exhibit different characteristics, indicating the need for high-quality research in the future to achieve per...

Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.

Endometrial cancer is a prevalent gynecologic malignancy found in postmenopausal women. However, in the last two decades, the incidence of early-stage has doubled in women under 40 years old. This stu... This retrospective study analyzed patients with early-stage endometrial cancer at 13 medical institutions in China from 1999 to 2015. The patients were divided into two groups: young (≤ 45 years old) ... The study involved 1,280 patients, 150 of whom were 45 years old or younger. The young group exhibited a significantly higher proportion of stage II, low-risk, lower uterine segment infiltration (LUSI... In the present study, young patients had better characteristics than the non-young group, while they exhibited higher levels of aggressiveness in certain aspects. The LRFS and OS outcomes were better ...